Ambu-logo-Red-800px.png
Interim report for Q2 2020/21 and the half-year
12 mai 2021 01h57 HE | Ambu A/S
(1 October 2020 to 31 March 2021) Ambu’s revenue increased organically by 6% in Q2 and by 20% in the half year driven by the rapid growth of our Visualization business. The revenue from our portfolio...
logo.png
Ambu A/S: Capital increase in connection with exercise of warrants issued
05 févr. 2021 05h42 HE | Ambu A/S
Capital increase in connection with exercise of warrants Ambu A/S issued 770,000 warrants in 2015 and 419,500 warrants in November 2016. Each warrant entitles the holder to subscribe for one Class B...
logo.png
Registration of share capital increase of 4,711,832 new B shares completed
01 févr. 2021 02h48 HE | Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
logo.png
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
29 janv. 2021 07h31 HE | Ambu A/S
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29...
logo.png
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
29 janv. 2021 07h30 HE | Ambu A/S
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29...
logo.png
Launch of Long-Term Incentive Plan
29 janv. 2021 07h24 HE | Ambu A/S
In accordance with the Remuneration Policy approved at the annual general meeting on 17 December 2019, Ambu A/S has today launched a long-term incentive plan for the Executive Board. In addition, 186...
logo.png
Completion of accelerated bookbuild offering
28 janv. 2021 01h36 HE | Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
logo.png
Status on accelerated bookbuild offering – Priced at DKK 262 per B share
27 janv. 2021 17h52 HE | Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
logo.png
Interim report for Q1 2020/21
27 janv. 2021 01h59 HE | Ambu A/S
Ambu delivered organic revenue growth of 39% in Q1. The demand for single-use endoscopes is positively influenced by COVID-19. Commercial launch of aScope™ Duodeno is on track, and clinical trial has...
logo.png
Ambu A/S seeks to strengthen its capital base
27 janv. 2021 01h57 HE | Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...